<SEC-DOCUMENT>0001144204-17-050352.txt : 20170928
<SEC-HEADER>0001144204-17-050352.hdr.sgml : 20170928
<ACCEPTANCE-DATETIME>20170928152331
ACCESSION NUMBER:		0001144204-17-050352
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20170926
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170928
DATE AS OF CHANGE:		20170928

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STAAR SURGICAL CO
		CENTRAL INDEX KEY:			0000718937
		STANDARD INDUSTRIAL CLASSIFICATION:	OPHTHALMIC GOODS [3851]
		IRS NUMBER:				953797439
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-11634
		FILM NUMBER:		171107281

	BUSINESS ADDRESS:	
		STREET 1:		1911 WALKER AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016
		BUSINESS PHONE:		6263037902

	MAIL ADDRESS:	
		STREET 1:		1911 WALKER AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STAAR SURGICAL COMPANY
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v476099_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>



<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>WASHINGTON, DC 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CURRENT REPORT Pursuant to</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Section 13 or
15(d) of the Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Date of report (Date of earliest event reported):
September 26, 2017</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>STAAR Surgical
Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Exact Name of Registrant as Specified in
Charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Delaware</FONT></TD>
    <TD STYLE="width: 2%; text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">0-11634</FONT></TD>
    <TD STYLE="width: 2%; text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">95-3797439</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(State or Other Jurisdiction </B><BR>
<B>of Incorporation)</B></P></TD>
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Commission</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>File Number)</B></P></TD>
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(I.R.S. Employer</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Identification No.)</B></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 80%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1911 Walker Ave., Monrovia, California</FONT></TD>
    <TD STYLE="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 45%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">91016</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Address of Principal Executive Offices)</B></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Registrant&rsquo;s Telephone Number, Including
Area Code <U>626-303-7902</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not Applicable</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Former Name or Former Address, if Changed Since Last Report)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 162.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<I>see</I> General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Written communication pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement communication pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement communication pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 26.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1 933 (17 CFR &sect;230.405) or Rule 12b-2 of the Securities Exchange Act
of 1934 (17 CFR &sect;240.12b-2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Emerging
growth company&nbsp;</FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</FONT> <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.75in"><B>Item 5.02</B></TD><TD><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers. </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">On September 28, 2017, STAAR Surgical Company
announced that its Board of Directors appointed Deborah Andrews to serve as Chief Financial Officer.
Ms.&nbsp;Andrews, age 59, has served as STAAR&rsquo;s Chief Accounting Officer since September 2013 and prior to that, from August
2005 to September 2013 she served as STAAR&rsquo;s Chief Financial Officer. She has been employed by STAAR since
1995, serving as Principal Financial Officer from April 2005 to August 2005, Global Controller from 2001 to 2005, Vice President,
Finance, of STAAR Surgical AG (Switzerland) from 1999 to 2001, and Assistant Controller from 1995 to 1999. She previously served
as an internal auditor for Bourns,&nbsp;Inc., a maker of electronic components, from 1994 to 1995, and an auditor for KPMG Peat
Marwick from 1991 to 1994. Ms.&nbsp;Andrews earned her B.S. in Accounting from California State University, San Bernardino.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">There are no family relationships between Ms.
Andrews and any director or executive officer of the Company, and she has no direct or indirect material interest in any transaction
required to be disclosed pursuant to Item 404(a) of Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In connection with the appointment of Ms.
Andrews as its Chief Financial Officer, STAAR increased Ms. Andrews&rsquo; annual salary to $335,000, with eligibility to
receive an annual incentive target bonus equal to up to 45% of her base salary, at the discretion of the Board of Directors
based on meeting financial and non-financial goals, and was also granted long-term incentive equity. Ms. Andrews has
previously entered into a change of control agreement in the form used by STAAR for its executive officers and severance
arrangements in the event of a termination without cause providing for payments of then-current base salary at a level
depending upon the length of service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.75in"><B>Item 9.01</B></TD><TD><B>Financial Statements and Exhibits</B></TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(d) Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 11%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 87%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="v476099_ex10-45.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.45</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="v476099_ex10-45.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Letter of the Company dated September 27, 2017 to Deborah Andrews, Chief Financial Officer, regarding compensation</FONT>.</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><A HREF="v476099_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="v476099_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">News Release, dated September 28, 2017, announcing the appointment of Deborah Andrews as Chief Financial Officer.</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">STAAR Surgical Company</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 31%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 28, 2017</FONT>&nbsp;&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Caren Mason</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Caren Mason</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.45
<SEQUENCE>2
<FILENAME>v476099_ex10-45.htm
<DESCRIPTION>EXHIBIT 10.45
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.45</B></P>

<P STYLE="margin: 0"><B></B></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><IMG SRC="image_002.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">September 27, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Re: Promotion</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Deborah,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Congratulations on your new and important role with the Company.
We wish you much success!</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">STAAR Surgical has made the following changes in the terms of
your employment, effective October 2, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>Your new title will be Chief Financial Officer&#9;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>Your annual salary will be $335,000&#9;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>Target Bonus will be 45% of your annual salary</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD>The Board of Directors have approved a grant of 25,000 stock options and 12,500 restricted stock units of STAAR Surgical Company
Stock. The grant will be effective and priced on November 13, 2017.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5.</TD><TD>You will report directly to Caren Mason (President and CEO)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Deborah, we appreciate the significant contributions you have
made to the Company and look forward to a successful future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 24%; border-bottom: Black 1pt solid"><IMG SRC="image_003.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid">9/27/2017</TD>
    <TD STYLE="width: 68%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>William Goodmen</TD>
    <TD STYLE="text-align: center">Date</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>VP Global Human Resources</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">Cc:</TD><TD STYLE="text-align: justify">Caren Mason</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>v476099_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><IMG SRC="v476099_ex99-1logo1.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>STAAR Surgical Names Deborah Andrews
as CFO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Surindra Mann Joins STAAR as Vice President,
Global Financial Planning &amp; Analysis</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>MONROVIA, CA, September 28, 2017</B>&mdash;STAAR
Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems
for the eye, announced today that Deborah Andrews, Interim CFO, has agreed to resume her role as Chief Financial Officer for the
company (held previously from 2007 &ndash; 2013). Joining Deborah&rsquo;s team as Vice President, Global Financial Planning &amp;
Analysis is Surindra Mann. Both appointments become effective October 2, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&ldquo;My decision to take on the role
of CFO was solidified as I worked closely with Caren and the team in a broader capacity these past five months,&rdquo; said Deborah
Andrews. &ldquo;I have a strong and enduring commitment to this company and its shareholders and have never been more confident
of its current and future promise as we have successfully completed several strategic milestones. Bringing on Surindra provides
further depth and breadth of experience for the finance team as we take the company to the next level,&rdquo; added Andrews.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;I am thrilled that Deborah has enthusiastically agreed
to resume her role as CFO for STAAR. It has been a pleasure working more closely with her since she assumed the position of Interim
CFO. We conducted a thorough outside search for CFO and were presented with several candidates who met our qualifications. However,
when Deborah expressed an interest in being considered last month, we realized that we had a winning combination in promoting Deborah
and hiring Surindra,&rdquo; said Caren Mason, President &amp; CEO. &ldquo;Surindra brings eighteen years of progressively responsible
experience to STAAR from her tenure with Abbott Global Healthcare. In her most recent position with Abbott, she held the position
of Global Finance Director, Financial Planning and Analysis for Abbott Medical Optics. She also held the positions of Global Assistant
Controller for Abbott Medical Optics, Business Unit Controller for Abbott Diabetes Care and as Senior Financial Analyst for the
Pharmaceutical and Diagnostics Divisions. We are very pleased to have these strong and accomplished executives leading our financial
operations,&rdquo; added Mason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I><U>About STAAR Surgical</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">STAAR, which has been dedicated solely to ophthalmic surgery
for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems.
These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses.
All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive
surgery is called an Implantable Collamer&reg; Lens or &quot;ICL&quot;. More than 700,000 Visian ICLs have been implanted to date.
To learn more about the ICL go to: www.discovericl.com. STAAR has approximately 340 full-time equivalent employees and markets
lenses in over 60 countries. Headquartered in Monrovia, CA, the company operates manufacturing facilities in Aliso Viejo, CA and
Monrovia, CA. For more information, please visit the Company's website at www.staar.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I><U>Safe Harbor</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All statements in this press release that are not statements
of historical fact are forward-looking statements, including statements about any of the following: future prospects of the Company,
achievement of milestones, and any assumptions underlying any of the foregoing. Important factors that could cause actual results
to differ materially from those indicated by such forward-looking statements are set forth in the Company&rsquo;s Annual Report
on Form 10-K for the year ended December 31, 2016, under the caption &ldquo;Risk Factors&rdquo;, which is on file with the Securities
and Exchange Commission and available in the &ldquo;Investor Information&rdquo; section of the company&rsquo;s website under the
heading &ldquo;SEC Filings.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">These statements are based on expectations and assumptions as
of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ
materially from those described in the forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTACT:</FONT></TD>
    <TD STYLE="width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investors</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EVC Group</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Moore, 310-579-6199</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Doug Sherk, 415-652-9100</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>v476099_ex99-1logo1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 v476099_ex99-1logo1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ &@%. P$1  (1 0,1 ?_$ ,    (!! ,! 0
M      @)!P ! @H#!08$"P$  @(# 0$               $"! ,%!@<($
M!@$"! ,$!@0)!PT    ! @,$!08'$0@ ,1()(3(305%A%")"8C,5"G&!P1:A
ML5)R@D-C-#;PHB-3)#47D;+"<_-D)28W1Q@X.1$  0,"! ,%! <&!P
M 0 1 @,$(3%!!5$2!F%Q@2(R\)$3!Z&QP='A- A"(S,41#7Q8H*BTG,8_]H
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M4'PUT!_LOJZD"HM_,Y'5-VM;*J0X-SKYLPV@14"@55N8]E5(<XGU, F!-+I
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M;24C'(8R@)?^4@ 43G*<$R'*'U- .73Q'AZE/51;W;LN(X1WS]I')KJFY#R
MUJV2MPZAJ7B:M+6W(%B5?XP3C2M*W6VZZ"DXH"P@HX3 Y?03^EJ.O#YC$B21
M4$;N^XPV[HN"\_=OK:1M#W&V_-]R;LL;9#<9IQHVH-2VZC+R#)<;ID1>5DU7
ML=,0;,AG+%%NB8QU@)_I UXR?'F<ABA/C@Z]9MO&S]A7&$L:RV[".W08EI,.
M ^9).SV/,;*IM)$R9BB=<CB7C2Z$-XF*/CQ&4Y3S9PF,DN+L@X]H=.[?%+W-
M,XXUVS=N7;7G/V>+XV;EF+]>;Q+V2:>/:\O(F/\ B!585NT19-(WK32(H4"
M4-=>( L,,TEV5:[E.VJ][K,%4^\;+]TF)<YY8G9W$N),K9YVVHT@PHMTU9J>
MA(B].I1W*LHITBB"_II"!# (#IH/ _-A^T2C!9?F BD#M<9G "E\+;AU0@E$
M#>FL&3:VN5=,Y=/](57Z0#RU]G!^R>\?:@IAV;[U8L8[.\HY'J#4[RU4#;K:
MK=66B0&$ZTY XX>R484@%U,)BNT"B !XB(<,ECX#ZD(*NRGA?&>.=A&#\AU$
M&4]?-QE3:9QS5E'1)>S9*RA>P7D[%+62:Z0?.G$0J;Y)) 1*FU*GH!=?'A!P
M'"83-E,58X7OB&45Z565LD-8)>KM;XI"1AK@WK3LY5'4"G9/E?QG\*<+$ YD
M16$O6 "&G!@FP49;K,]57:IMTS/N$M[Q-I7<08TLUU<IK *AWKJ%C5#Q#%+7
M5=X[?RGH-TT@$3J'6  U'@##'@D6"U=IO99EFA]IVD;_ -.OOD]]-1W()]TZ
MT+F8.U[ JUGID[NPX\25^7.H!28<<I(_+'.!>HAA$= \#E/+S,?L26US@O,-
M3SWAS&&::,_;R%2R?2*Q=H-=L=-4 86*,:O ;*"D<R:;E@Y7,BJ4!'H.00'Q
M >+0I0(?%-TI'#(B/?\ ]Z"(&$B9-C&W@2E+R 1M+M50WB ^*HFT-[P /;X\
M2C2A&7,'=)/*,D4P  B;0#%,( (!KTCJ!1\/+K_%QD0HVM^(,>7EV^?VNNMY
MAW)UC]S'RRRSE([BL?B[>?"(.+99 0;A+M2+@8-% .'FT\.*UQHA> :;4=O3
M"-F(9GBZNMX>?>1LC,1:9'/R+^1B<CK9<8/ED!<"7YI#(RWXKUAH(N"EU^@
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M=W.5*U/.*G(+5^HR)3U7&<8H^E!,E\TW<*DFGM?3<F66?&;E ZJ)#B!1]/0
M,(AW5MT]3V&R%2H/XN#\6QX!>%[K\PMK^8>XFTW"7[^W//;AQA,^7#$XLC9K
MVV;>AOCD8*7W$SCC$^'V*J0Q-/%N,0Z:0R?0DU_ *NU7.N$D=NGT%?/PU*&F
MB8>(<<9=[C9[55E.W8U')+8X]I7JW371'S"ZFJ"GU#+EZ:E$ 0\P'( V ,-6
MXYIX^%,,8_P308;'F.XDD9!PY-!4.!32,H\$G2O*3#L"D4?2;K34ZA@]P!H
M!QQNX;M5W2ZE<U2#*3##(-@P7T%TWT?LW2FW4]MV2 IV<"2!QE(DR/O*BW>C
M@V][D-M>7<&XUS%+X)NF2*P> ALH0C9-^_KI#N2+O4%&QCMU2,99JD9FLH@J
M#H$UA$@E-H/&NG1%4$E='(FH.71:WL'MC_,UX=H+W M'SG@K*.-CQ*]8BLB6
MZ:K3RU,:XY05C 22E+6Q/:!409+"*8JD653$  #B(!Q3:0P&2O/3)Q]03/NR
MYVNI7ML8MOR60[S"7W-6;K*TL^0)&JIN$JE#,H5N\0KU?A?Q%%*1?'2-).55
MG2P H<XB!0], '@R':L=67-ED/K3:<UUB7NV'\ITR !%2;MV.;Q6(A%PJFW;
M+24_6)2*8D<.5"'*W1!R[*)CZ?1 .%HJYR2A.PKL&W ]O?;%DS%&XQO34+=:
MLQ/KU&!2["-A8C"/*S Q2(.G (($1= M&'U*43 .HCQ9M_2>]11@]SO&.Y+-
M>SS+N&MJ0UY/*N5HEI1%Y"RV-*KL8*CS*QTKG)-9,4EUAD312@HD(!=1*N/2
M("'&="07@/\ *PXS3Q/27.>]R&=:EF%S%D?Y$K6&9Z 9T)E/+&!JBWA'"L #
MF42B69"HBX<"JH8@\PT 1I2B.8N=5;C4(B !HI:[?_9SW2]M;N4R^2\+62%R
M!LTNU,6I5Q?72WM6>5W4:_B6LN60>UYFR0C7DA7L@LQ^6.42F%BLKX"8W$6(
M[D5)"4#Q30N\-@/=CNJV:V;;QM/;TT]DRQ8(2,N<G<;2-28Q>/XU=&<>,DE_
MDY [Y>=>,$FRZ/I&!1N<Y? #:A'1@JC)1V+/RL6#FV-:8CD3<IN+@\AJUMBY
MO\5CZ?JJ-'+:7*)U9M.$9'KB N6OJ',B4ZA1,<.D3"/E  #8DOW?BAE,7:K[
M6>Z[ME[V\V(Q4]5;OLFRG$%BXV6E;>T#)17D$<'U-LDS66, P8!)F<+JL5OE
MC]'3H;P#F9%M$(\.]5LSS#OSV/SNWK!RE6;Y E<C8\M3%*XR:D+#&8UB<!W(
MHJNTV[A0#ZN $I@T 1#P]W#S"M4B(ASDEV;HNQ+9LP;.]ILMB=S4L0]P+:SB
M_&]<1N5>D",JK=I:HLFQG;&7DV3-NJ[D8^7;BJPE%" HH/@J)R"  V<!LU(S
M )!R*>/LD=[M5\"U:*WJUBC0F>H!((&>F\>V9"RUR\QS$O0QN[=))DQ4AG<H
MF >HS.43H*:CR'3A/QS50*$MV-5[EM9S#7<P;,;OA7(= ;U *Y==J>;$9*I1
MT[*D=F<A<:AE."24<QL^NB()J ^1,W*0FFAM=.#%\$8H,;IMC[B/<'S'MEE=
MY&/L";8MO>V3,E>SNC4,:7U]E[)&4+[4/43@XMS.#&1<-7:JBNL8%RD(+A;0
M!U$O!F,69+-.2W 8/I^XW">5\$7I1P>F9:I%FI-@,U,!WS5I9&JJ1WS-4YN@
MJ\:Y4*JB&@AJD!0Y<":3GAR$[U6SS&==VT4S$^V/=O1\:Q+2DXCSG9,I2V+K
M,-,BVY8^J-LBTP[%Z=U(PL2FDFLY;J@544=--1 >!SDP/#V^]+%%GV[MEN4-
MN\EGS/NYB^0>3-UVZ^W1MURS.TQDY88\I\1!H#'53&-"2?E3D!A*\V6-JNL7
MK5.7J#0/ 0?24QVKO]V&UG)N7MYO;VSY3S0!*1MEN67IS)B,I*NVLY^&W2@*
M5N%/6D$"G(X.:0-_M)!$H')H!O?PN"%"&]O8ME];</C;?ML/D:Q2=V%/>1-1
MRA2K'($K^.]RN(7;OIEZK>%VR#A(EI@D'!S,)59/U-4RI^H'APR3F$NU-MAE
M7\A7XU6RQ;6,?R$2U"<@C/DY5FQ6=M^A_%G>IE^7D6X+J'3(IT$(=,-1]W %
M)(Q@]JO<([<]JR"UV 1F(=Q^T[(%OFLA-MLV9K3(T.ZX6MME7/(V:.QE>F2:
MT*\J+MZ?U4F;LA01,80 0\#"98#$*/<O8XWVM;[]V>YS >ZON &Q!@RH;69N
M5NF#-N.$91[=9I[>Y^'/".K/DS)$H4$U&Z$4J=,L='IF(81 1,&G#<OS<$,B
M=[K^V?*F[W9!DO N'4(9UD.SV''$G$MK',MXF,%E6;O!STB=S)KI>DGZT?&J
METTU'JT >$<FU=,I@;*"0"FL:W,MV[UL>M,J_*,G!?6:NT1C"QL@W6+H8%6[
MA QR&#00,4>$^J$BRH;9>Y%VUY2UT_8A$8FW:;09R?F+74,$9BN#W'.4,&R-
M@?&DIFM42ZIHKP$[13N53'9M%R JB81#73B0<8#'V]LD99(O-ID1W.KGF">S
M'O)L^&\2XT-5'E;INU##H+7,R,HZ<(O$+E=<IRJ#=R%@9MR"@#=D0[;Z0\)Y
M,VB,5Y'NO;4<\;YZ%@_;10'K&OX*MN::U9]TMW3LA(.SQ>+*BX3DT8"GQHD,
MK*RLS(AS.'IIBB4QBB <!R9!4;J]DO%CN"<5IQO*[ABM:<1/[O*5M7<K)*0I
MX%9HM$F@9",3C3,))FFQ$4#IB42B@ %^/ T>)]O%#*4^TWM?W#[+<&7O;#EY
M>&FL<XWR[<@VU7"-GF\Y,V'"DU(N)J)9V%NDDU7AIJ-=.!3*"W5U>/+P#B^,
M@DAVR[@SN*XM[FV:=Y>U+"6$<U4C+&WW%6&?ELFYA=8Y?1K^E/UY>3DOE6$,
M_!4 56%N AKJ! T\=>&A'SM1R9W#+C=;'%;O]M^#,-TII">O5['BW,C_ "-)
MS$\5^5,T:_B7<2R-'-OPT?6!0QM1'P^' A'R;V<5Z^03"QT#BLP38*A_RUXR
M#Q2EX>*L/+V<O;RY?Q<1.:8S"\5;/\-V+_"_^['O^*O\._W93_??_<O]9_9Z
M\7;'\S'^/_IS_P %I=]_)2_*9?U/I\.WAVI"MS_]0I?_ /,G[\O^\_O.8???
M:XZ77^J^U><'7^S_ &)H&U[^XL?_ *G_ -R_]DOOO.G_ ';^P]_VM.,-Y_#'
MYS7U>G+V?L6VV/\ ,'^R:>CUYHV ^^'[GRAR_O'_ &?N_7QHSEJO28^G[LES
ME_5^KGS'GQ2J>M2T7&IR#[KSA]YRYAR^WPO>A9&^M^@>?+]?PXQZJ.JP+Y_Z
MKF7EY_NS<_M>[[.O %)<IN0_MY?K^' <D')6)Y0Y<@\O+E[/A[N''+5(+!3G
M_5^4WWGZO\WW_JX#GJD<UF']'ZW+GS#_ "'X\"F,E7U_J<@_G^W^#@0L3\B?
M=^8/-^@?N_M^[X<!R2.2L/F#R\O;YN8<OAQ%15B\@\G(/+R\WL^'[>!!6?\
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%;A)K_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !( ,X# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
)110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  9 )P# 2(  A$! Q$!_\0
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210 4444 %)2T4 )2T44 ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
